Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1

Journal of Medical Virology

Volumn 84, Issue 2, 2012, Pages 194-197

  Lascaux, Anne Sophie ^a   Caumes, Eric ^b   Deback, Claire ^b   Melica, Giovanna ^a   Challine, Dominique ^a   Agut, Henri ^b   Lévy, Yves ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Aciclovir resistance; AIDS; Foscarnet resistance; HIV; HSV; Imiquimod

Indexed keywords

ACICLOVIR; FOSCARNET; IMIQUIMOD; LAMIVUDINE; NELFINAVIR; VALACICLOVIR; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; GENITAL HERPES; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE;

ACYCLOVIR; ADMINISTRATION, TOPICAL; ADULT; AMINOQUINOLINES; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; FOSCARNET; HERPES SIMPLEX; HIV INFECTIONS; HIV-1; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; NELFINAVIR; SIMPLEXVIRUS; ZIDOVUDINE;

EID: 83655182790     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23188     Document Type: Article

References (15)

1. Bernstein DI, Spruance SL, Arora SS, Schroeder JL, Meng TC. 2005. Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: A pilot study. Clin Infect Dis 41:808-814.
2. Brummitt C. 2006. Imiquimod 5% cream for the treatment of recurrent aciclovir-resistant genital Herpes. Clin Infect Dis 42:575.
3. Christensen B, Hengge UR. 1999. Recurrent urogenital herpes simplex-successful treatment with imiquimod. Sex Trans Infect 75:132-133.
4. Danielsen AG, Petersen CS, Iversen J. 2002. Chronic erosive herpes simplex virus infection of the penis in a human immunodeficiency virus-positive man, treated with imiquimod and famciclovir. Br J Dermatol 147:1034-1036.
5. Danve-Szantanek C, Aymard M, Thouvenot D, Morfin F, Agius G, Bertin I, Billaudel S, Chanzy B, Coste-Burel M, Finkielsztejn L, Fleury H, Hadou T, Henquell C, Lafeuille H, Lafon ME, Le Faou A, Legrand MC, Maille L, Mengelle C, Morand P, Morinet F, Nicand E, Omar S, Picard B, Pozzetto B, Puel J, Raoult D, Scieux C, Segondy M, Seigneurin JM, Teyssou R, Zandotti C. 2004. Surveillance Network for Herpes simplex virus resistance to antiviral drugs: 3-Year follow-up. J Clin Microbiol 42:242-249.
6. Gilbert J, Drehs MM, Weinberg JM. 2001. Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection. Arch Dermatol 137:1015-1017.
7. Levin M, Bacon T, Leary J. 2004. Resistance of Herpes simplex virus infections to nucleoside analogues in HIV-infected patients. Clin Infect Dis 39:S248-S257.
8. Mark K, Corey L, Meng TC, Margaret A, Huang ML, Selke S, Slade H, Tyring S, Warren T, Sacks S, Leone P, Bergland V, Wald A. 2007. Topical resquimod 0.01% gel decreases Herpes Simplex virus type 2 genital shedding: A randomized, controlled trial. J Infect Dis 195:1324-1328.
9. Martinez V, Molina JM, Scieux C, Ribaud P. 2006. Topical imiquimod for recurrent aciclovir-resistant HSV infection. Am J Med 119:e9-e11.
10. Reyes M, Shaik NS, Graber JM, Nisenbaum R, Wetherall NT, Fukuda K, Reeves WC, Task Force on Herpes Simplex Virus Resistance. 2003. Aciclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med 163:76-80.
11. Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J, Kessler HA, Landry B, Mills J. 1991. A controlled trial comparing foscarnet with vidarabine for aciclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N Engl J Med 325:551-555.
12. Safrin S, Kemmerly S, Plotkin B, Smith T, Weissbach N, De Veranez D, Phan LD, Cohn D. 1994. Foscarnet-resistant herpes simplex virus infection in patients with AIDS. J Infect Dis 169:193-196.
13. Schmit I, Boivin G. 1999. Characterization of the DNA polymerase and thymidine kinase genes of herpes simplex virus isolates from AIDS patients in whom acyclovir and foscarnet therapy sequentially failed. J Infect Dis 180:487-490.
14. Spruance SL, Tyring SK, Smith MH, Meng TC. 2001. Application of a topical immune response modifier, resiquimod gel, to modify the recurrence rate of recurrent genital herpes: A pilot study. J Infect Dis 184:196-200.
15. Strick LB, Wald A, Celum C. 2006. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. Clin Infect Dis 43:347-356.